Analyse produit facultative
Avec votre autorisation, nous utilisons une analyse limitée et respectueuse de la vie privée pour comprendre les parcours de recherche utiles. Nous n’utilisons ni traceurs publicitaires ni enregistrement de session. Vous pouvez modifier ce choix dans les préférences. Consultez la Politique de confidentialité.
Nordson Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $18.3B | |
|---|---|---|
| P/E (forward) | 24.8x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | Trend |
| Revenue | $2.36B | $2.59B | $2.63B | $2.69B | $2.79B | +4.3% |
| Gross profit | $1.32B | $1.43B | $1.43B | $1.49B | $1.54B | +3.8% |
| Operating income | $615.1M | $702.4M | $672.8M | $674.0M | $711.7M | +3.7% |
| Net income | $454.4M | $513.1M | $487.5M | $467.3M | $484.5M | +1.6% |
| EPS (diluted) | $7.74 | $8.81 | $8.46 | $8.11 | $8.51 | +2.4% |
| EBITDA | $703.6M | $771.6M | $786.7M | $810.6M | $849.3M | +4.8% |
| R&D | $59.4M | $52.5M | $71.4M | $65.0M | $68.2M | +3.5% |
| SG&A | $709.0M | $724.2M | $752.6M | $812.1M | $815.5M | +3.6% |
Recent company headlines from major financial publishers.
The Base scenario carries a probability of 60.0% and establishes a target valuation of $206.83, implying a projected return of -37.0% relative to $328.17. This path assumes that precision dispensing demand remains steady across industrial manufacturing and that order backlog converts cleanly over an operational turnover horizon without supply disruptions. Operating margins expand gradually as operational efficiencies under NBS Next offset moderate price and cost pressures. Disconfirmation would emerge if quarterly order intake slows or if incremental margins fail to meet management expectations, signaling competitive share losses or end-market softening.
The Bull scenario represents a probability of 20.0% with a target valuation of $255.82, yielding an implied return of -22.0% against $328.17. In this trajectory, an extended semiconductor advanced packaging investment cycle accelerates high-margin equipment shipments in Advanced Technology Solutions, while medical fluid component adoption accelerates. Operating margins expand robustly as strong operating leverage delivers incremental margins at the top end of management targets. Disconfirmation of this optimistic path would occur if electronics packaging orders plateau or if customer capital expenditure budgets tighten across key manufacturing regions.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.3% | $221 | $226 | $231 | $236 | $242 |
| 8.8% | $210 | $214 | $218 | $222 | $227 |
| 9.3% | $200 | $204 | $207 | $210 | $214 |
| 9.8% | $192 | $194 | $197 | $200 | $204 |
| 10.3% | $184 | $186 | $189 | $191 | $194 |
Upcoming earnings date and setup when available.
La notation portée par l'édition de recherche publiée chaque mois. Une notation compare le cours à la date d'analyse à la juste valeur ; elle n'indique pas si l'appréciation s'est révélée juste.
| Année | janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |